<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT: INTRODUCTION: Among various <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> renal vascular changes, <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathy</z:e> (<z:chebi fb="39" ids="18139,53050">TMA</z:chebi>) presented with the most severe clinical manifestations and high mortality </plain></SENT>
<SENT sid="1" pm="."><plain>The pathogenesis of <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) was complicated </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess clinical manifestations, laboratory characteristics, pathological features and risk factors for clinical outcomes of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> patients co-existing with renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> in a large cohort in China </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Clinical and renal histopathological data of 148 patients with biopsy-proven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> were retrospectively analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>Serum complement factor H, A Disintegrin and Metalloprotease with Thrombospondin type I repeats 13 (ADAMTS-13) activity, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and C4d deposition on renal vessels were further detected and analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In the 148 patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo>, 36 patients were diagnosed as co-existing with renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> based on pathological diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain>Among the 36 TMA patients, their clinical diagnoses of renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> were as followings: 2 patients combining with thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo>-<z:hpo ids='HP_0005575'>hemolytic uremic syndrome</z:hpo>, 2 patients combining with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome, 2 patients with malignant <z:hpo ids='HP_0000822'>hypertension</z:hpo>, 1 patient with <z:hpo ids='HP_0100324'>scleroderma</z:hpo> and the other 29 patients presenting with isolated renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with the non-renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> group, patients with renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> had significantly higher urine protein (7.09 ± 4.64 vs. 4.75 ± 3.13 g/24h, P = 0.007) and serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> (159, 86 to 215 vs. 81, 68 to 112 μmol/l, P &lt;0.001), higher scores of total activity indices (AI) (P &lt;0.001), endocapillary hypercellularity (P &lt;0.001), subendothelial hyaline deposits (P = 0.003), interstitial <z:mp ids='MP_0001845'>inflammation</z:mp> (P = 0.005), glomerular <z:mp ids='MP_0002498'>leukocyte infiltration</z:mp> (P = 0.006), total chronicity indices (CI) (P = 0.033), <z:hpo ids='HP_0000092'>tubular atrophy</z:hpo> (P = 0.004) and interstitial <z:mp ids='MP_0003045'>fibrosis</z:mp> (P = 0.018) </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> presented with poorer renal outcome (P = 0.005) compared with the non-<z:chebi fb="39" ids="18139,53050">TMA</z:chebi> group </plain></SENT>
<SENT sid="9" pm="."><plain>Renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> (hazard ratio (HR): 2.772, 95% confidence interval: 1.009 to 7.617, P = 0.048) was an independent risk factor for renal outcome in patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The renal outcome was poorer for those with both C4d deposition and <z:hpo ids='HP_0005369'>decreased serum complement factor H</z:hpo> in the <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> group (P = 0.007) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: There were various causes of renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Complement over-activation via both classical and alternative pathways might play an important role in the pathogenesis of renal <z:chebi fb="39" ids="18139,53050">TMA</z:chebi> in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
</text></document>